Has Wendy Roberts, MD received payments from drug or device companies?

Yes. Drug and device makers reported $60,448 in general payments to Wendy Roberts, MD across 97 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wendy Roberts, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wendy Roberts, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wendy Roberts, MD

Dermatology · Rancho Mirage, CANPI 1689663635

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $49,921 of the $60,448 with a category attached, or 82.6%. AbbVie accounts for 79.0% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2020 at $18,358 and has fallen 86.0% since, to $2,566 in 2025. Among dermatology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$60,448in general payments, 2019–2025

Across 97 payments — averaging $623.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$48K
Solta Medical, A Division Of Bausch Health US, LLC$7K
Ortho Dermatologics, A Division Of Bausch Health US, LLC$2K
Incyte Corporation$2K
Galderma Laboratories, L.p.$363
Lilly USA, LLC$178
plus $787 from 14 others

$157,531in research payments, 2019–2025

Across 11 payments — averaging $14,321 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$158K

What the payments were for

Consulting fees$49,92183%
Speaking & faculty fees$1,6003%
Grants$5,0008%
Travel & lodging$4861%
Food & beverage$3,4426%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	34	$47,739
Solta Medical, A Division Of Bausch Health US, LLC	1	$6,800
Ortho Dermatologics, A Division Of Bausch Health US, LLC	11	$2,293
Incyte Corporation	4	$2,287
Galderma Laboratories, L.p.	14	$363
Lilly USA, LLC	7	$178
Revance Therapeutics, Inc.	1	$136
Sanofi	4	$126
Endo Pharmaceuticals Inc.	2	$102
Johnson & Johnson	4	$93
E.r. Squibb & Sons, L.L.C.	1	$56
Organon	3	$40
Apyx Medical Corporation	2	$36
Regeneron Healthcare Solutions, Inc.	1	$36
Sun Pharmaceutical Industries Inc.	2	$32
Krystal Biotech Inc	1	$32
LEO Pharma Inc.	1	$28
UCB, Inc.	1	$26
Sensus Healthcare, Inc.	2	$26
Kyowa Kirin, Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BOTOX COSMETIC$10,057
ALTRENO$1,753
BOTOX$1,600
DUOBRII$375
Skyrizi$241
DAXXIFY$136
NEMLUVIO$128
ARAZLO$120
JUBLIA$120

How this compares

$60,448 in reported general payments places this provider in the 90th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California →

Medicare billing

Part B allowed, 2024

$362,811

Medicare patients

395

Services billed

2,960

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	22	$753
Triamcinolone Acetonide	63	$656
Ketoconazole	35	$438
Imiquimod	14	$345
Acyclovir	11	$113
Cephalexin	15	$67

Paid to pharmacies, not to this prescriber.

Other dermatology in Rancho Mirage

Paul YamauchiSanta Monica$2.9M
Jennifer SoungSanta Ana$2.8M
Robert GreenbergLivermore$2.6M
Neal BhatiaSan Diego$2.5M
April ArmstrongLos Angeles$2.3M
Jeffrey CrowleyBakersfield$2.1M
Jashin WuCorona$2M
Raja SivamaniSacramento$1.9M
Tien NguyenFountain Valley$1.2M
Tina BhutaniSan Francisco$1.1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →